The epidemiology of viral hepatitis among people who inject drugs: Results of global systematic reviews
Explore this paper's citation graph
Summary
The prevalence of anti-HCV among IDUs is far greater than HIV, and better and more complete data and reporting are required to estimate the scale of the problem, to inform efforts to prevent and treat HCV and HBV among IDUs.
- Type
- review
- Published
- 2011-07-27
- Cited by
- 1,394
- References
- 40
- Access
- Open access
- OpenAlex
- https://openalex.org/W2104563699
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:24663356
Keywords
Medicine, HBsAg, Population, Epidemiology, Hepatitis B
References
- Hepatitis Delta Virus
- Drug injecting and HIV infection : global dimensions and local responses
- The increasing mortality burden of liver disease among opioid-dependent people: cohort study.
- 12 myths about HIV/AIDS and people who use drugs.
- Epidemiology of hepatitis B and C viruses: a global overview.
- Viral Hepatitis in Incarcerated Adults: A Medical and Public Health Concern
- Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment
- The linguistic demography of Australians living with chronic hepatitis B
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.
- Hepatitis A virus seroprevalence by age and world region, 1990 and 2005.
- Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.
- Epidemiology of viral hepatitis and HIV co-infection.
- People who use drugs, HIV, and human rights.
- What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews.
- Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
- Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.
- Tilting at windmills and the evidence base on injecting drug use
- Is severe liver disease a common outcome for people with chronic hepatitisC?
- Mathematical modelling of hepatitis C treatment for injecting drug users.
- HIV prevention, treatment, and care for people who inject drugs.
Cited by
- Methadone replacement therapy: tried, tested, effective?
- Global burden of hepatitis C: considerations for healthcare providers in the United States.
- Public health issues of hepatitis C virus infection.
- Burden of Infectious Diseases, Substance Use Disorders, and Mental Illness among Ukrainian Prisoners Transitioning to the Community
- Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells.
- A Unique Model for Treating Chronic Hepatitis C in Patients With Psychiatric Disorders, Substance Abuse, and/or Housing Instability
- Seroprevalence of hepatitis C and factors associated with this in crack users.
- Viral hepatitis among drug users in methadone maintenance: Associated factors, vaccination outcomes, and interventions
- Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study
- Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study
- Injecting drug use in low and middle‐income countries: Opportunities to improve care and prevent harm
- Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice
- Hepatitis C Virus Elimination in the Human Immunodeficiency Virus–Coinfected Population
- No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy
- Summary of available surveillance data on hepatitis C virus infection from eight Arctic countries, 2012 to 2014
- Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015
- Primary and secondary prevention of hepatitis C virus among rural appalachian people who use drugs
- The global state of harm reduction 2012. Towards an integrated response.
- Re-establishing Contact: A profile of clients attending the health promotion unit - needle exchange at Merchants Quay Ireland.
- Coherence policy markers for psychoactive substances.
Related papers
- Mutations Associated with Occult Hepatitis B Virus Infection Result in Decreased Surface Antigen Expression In Vitro
- Hepatitis B Virus Mutant Infections in Hemodialysis Patients: A Case Series
- Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H.
- Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes
- Application of HBsAg and HBcAg Immune Fluorescence Detection in Diagnosis of Hepatitis B Virus Associated Glomerulonephritis
- Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013
- Hepatitis B in Moroccan blood donors: a decade trend of the HBsAg prevalence in a resources limited country
- Immunity to hepatitis B vaccine among health care workers.
- False positive Hepatitis B Surface Antigen due to recent vaccination.
- Hepatitis B surface antigen positive rate and risk factors analysis of primary and secondary students in Sunan province Yugu autonomous